Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Pediatric migraine: Opioid use tied to longer hospital stay

Publish date:: June 15, 2020

Key clinical point: Use of opioids during pediatric migraine headache hospitalizations is associated with a longer length of stay and a higher rate of readmissions.

Major finding: Patients who received opioids had a significantly longer length of stay (mean, 49.1 vs. 35.6 hours; P less than .001) and a higher 30-day readmission rate (adjusted odds ratio, 2.0; P less than .001) compared with those who did not receive opioids.

Study details: A retrospective cross-sectional study of individuals aged 7-21 years who were hospitalized for migraine (6,632 hospitalizations; 5,371 unique patients).

Disclosures: The study was partly supported by a Eunice Kennedy Shriver National Institute of Child Health and Human Development award and funded by the National Institutes of Health. The authors declared no conflict of interest.

Citation:

Masonbrink A et al. Hosp Pediatr. 2020 Apr 15. doi: 10.1542/hpeds.2020-0007.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Headache & Migraine

HIT-6 may help track meaningful change in chronic migraine,

Choroid plexuses may play a role in migraine,

Multiple traits more common in difficult-to-treat patients with migraine,

Marijuana for migraine? Some tentative evidence,

Low vitamin D levels in patients with migraine,